Search research articles
Contact Us
Filters
Showing results (111-120 of 171) with videos related to
Page
of 18
Sort By:
Cancer Research
|
January 18, 2023
NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
Li Guan, Dhanya K Nambiar, Hongbin Cao, et al.
JCO Precision Oncology
|
September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype
Jordan Kardos, Sara E Wobker, Michael E Woods, et al.
Journal of the National Cancer Institute
|
February 5, 2019
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy
Maria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, et al.
Oncogene
|
June 20, 2025
Correction: An FGFR-p53 developmental signaling axis drives salivary cancer progression
Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
Science Advances
|
December 22, 2023
Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer
Mehdi Chaib, Jeremiah R Holt, Emilie L Fisher, et al.
Oncogene
|
June 2, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progression
Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
The Journal of Clinical Investigation
|
August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice
William Y Kim, Samanthi Perera, Bing Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2024
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity
Sarah Asemota, Wendy Effah, Jeremiah Holt, et al.
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Cancer Research
|
March 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment
Sofia Ferreira, Brittany M Flowers, Won-Young Choi, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 171) with videos related to
Sort By:
Page
of 18
Cancer Research
|
January 18, 2023
NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells
Li Guan, Dhanya K Nambiar, Hongbin Cao, et al.
JCO Precision Oncology
|
September 11, 2020
Comprehensive Molecular Characterization of Urachal Adenocarcinoma Reveals Commonalities With Colorectal Cancer, Including a Hypermutable Phenotype
Jordan Kardos, Sara E Wobker, Michael E Woods, et al.
Journal of the National Cancer Institute
|
February 5, 2019
Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy
Maria B Koenigs, Armida Lefranc-Torres, Juliana Bonilla-Velez, et al.
Oncogene
|
June 20, 2025
Correction: An FGFR-p53 developmental signaling axis drives salivary cancer progression
Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
Science Advances
|
December 22, 2023
Protein kinase C delta regulates mononuclear phagocytes and hinders response to immunotherapy in cancer
Mehdi Chaib, Jeremiah R Holt, Emilie L Fisher, et al.
Oncogene
|
June 2, 2025
An FGFR-p53 developmental signaling axis drives salivary cancer progression
Adele M Musicant, Julia M R Billington, Jeffrey S Damrauer, et al.
The Journal of Clinical Investigation
|
August 8, 2009
HIF2alpha cooperates with RAS to promote lung tumorigenesis in mice
William Y Kim, Samanthi Perera, Bing Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 23, 2024
A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity
Sarah Asemota, Wendy Effah, Jeremiah Holt, et al.
Advances in Radiation Oncology
|
November 24, 2022
Evolutionary Action Score of <i>TP53</i> Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234
Chieko Michikawa, Pedro A Torres-Saavedra, Natalie L Silver, et al.
Cancer Research
|
March 11, 2026
Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment
Sofia Ferreira, Brittany M Flowers, Won-Young Choi, et al.
Page
of 18